These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 21206983)
1. Gene therapy for oral squamous cell carcinoma with IAI.3B promoter-driven oncolytic adenovirus-infected carrier cells. Zhang T; Hamada K; Hyodo M; Itoh H; Tani K; Goda H; Nakashiro K; Hamakawa H Oncol Rep; 2011 Mar; 25(3):795-802. PubMed ID: 21206983 [TBL] [Abstract][Full Text] [Related]
2. Identification of the human IAI.3B promoter element and its use in the construction of a replication-selective adenovirus for ovarian cancer therapy. Hamada K; Kohno S; Iwamoto M; Yokota H; Okada M; Tagawa M; Hirose S; Yamasaki K; Shirakata Y; Hashimoto K; Ito M Cancer Res; 2003 May; 63(10):2506-12. PubMed ID: 12750273 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of oncolytic adenovirus expressing relaxin in radioresistant oral squamous cell carcinoma. Lee SY; Park HR; Rhee J; Park YM; Kim SH Oncol Res; 2013; 20(9):419-25. PubMed ID: 23924926 [TBL] [Abstract][Full Text] [Related]
4. Cloning of carrier cells infected with oncolytic adenovirus driven by midkine promoter and biosafety studies. Hamada K; Takagi S; Kuboshima H; Shimada H; Takagi K; Yasuoka T; Matsubara K; Sassa Y; Furuya T; Suzuki K; Uchide T; Mizutani T; Tani K; Itoh H; Sugiyama T J Gene Med; 2019 Feb; 21(2-3):e3064. PubMed ID: 30548997 [TBL] [Abstract][Full Text] [Related]
6. Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter. Hamada K; Shirakawa T; Terao S; Gotoh A; Tani K; Huang W Mol Ther Methods Clin Dev; 2014; 1():14019. PubMed ID: 26015963 [TBL] [Abstract][Full Text] [Related]
7. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes. Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145 [TBL] [Abstract][Full Text] [Related]
8. Carrier cell-mediated delivery of a replication-competent adenovirus for cancer gene therapy. Hamada K; Desaki J; Nakagawa K; Zhang T; Shirakawa T; Gotoh A; Tagawa M Mol Ther; 2007 Jun; 15(6):1121-8. PubMed ID: 17387337 [TBL] [Abstract][Full Text] [Related]
9. Intravenous injection of irradiated tumor cell vaccine carrying oncolytic adenovirus suppressed the growth of multiple lung tumors in a mouse squamous cell carcinoma model. Saito A; Morishita N; Mitsuoka C; Kitajima S; Hamada K; Lee KM; Kawabata M; Fujisawa M; Shirakawa T J Gene Med; 2011 Jun; 13(6):353-61. PubMed ID: 21674738 [TBL] [Abstract][Full Text] [Related]
10. Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers. Du T; Shi G; Li YM; Zhang JF; Tian HW; Wei YQ; Deng H; Yu DC Cancer Gene Ther; 2014 Aug; 21(8):340-8. PubMed ID: 25034886 [TBL] [Abstract][Full Text] [Related]
11. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity. Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462 [TBL] [Abstract][Full Text] [Related]
12. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma. Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438 [TBL] [Abstract][Full Text] [Related]
13. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma. Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790 [TBL] [Abstract][Full Text] [Related]
14. Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter. Cheng PH; Rao XM; Duan X; Li XF; Egger ME; McMasters KM; Zhou HS J Mol Med (Berl); 2015 Feb; 93(2):211-23. PubMed ID: 25376708 [TBL] [Abstract][Full Text] [Related]
15. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo. Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558 [TBL] [Abstract][Full Text] [Related]
16. Comparison of oncolytic adenoviruses for selective eradication of oral cancer and pre-cancerous lesions. van Zeeburg HJ; Huizenga A; Brink A; van den Doel PB; Zhu ZB; McCormick F; Brakenhoff RH; van Beusechem VW Gene Ther; 2010 Dec; 17(12):1517-24. PubMed ID: 20686507 [TBL] [Abstract][Full Text] [Related]
17. [Anti-Tumor Effect of a Novel Oncolytic Virus Based on Chimpanzee Adenovirus Type 6]. Wang Q; Wang YH; Li Y; Xing M; Zhou DM Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):71-76. PubMed ID: 35048603 [TBL] [Abstract][Full Text] [Related]
18. Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumors. Yamamoto Y; Nagasato M; Rin Y; Henmi M; Ino Y; Yachida S; Ohki R; Hiraoka N; Tagawa M; Aoki K Cancer Med; 2017 Oct; 6(10):2385-2397. PubMed ID: 28941156 [TBL] [Abstract][Full Text] [Related]
19. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation. Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155 [TBL] [Abstract][Full Text] [Related]
20. Reexpression of human somatostatin receptor gene 2 gene mediated by oncolytic adenovirus increases antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand against pancreatic cancer. Zhang Z; Huang Y; Newman K; Gu J; Zhang X; Wu H; Zhao M; Xianyu Z; Liu X Clin Cancer Res; 2009 Aug; 15(16):5154-60. PubMed ID: 19671855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]